Ecliptic Capital

Ecliptic Capital Research Investment Thesis Ecliptic Capital is an early-stage venture firm founded by seasoned ex-Fortune 500 operators who believe in deep operational engagement with founders. The firm's thesis is that innovation happens at the intersection of scientific breakthroughs and practical execution. They provide not just capital but hands-on mentorship, strategic guidance, and access to their network of 100+ years of combined operating experience. Ecliptic invests in disruptive technologies with global impact, backing founders who are building scalable, sustainable enterprises across three core focus areas. Three Core Investment Focus Areas Energy & Materials - Scientific breakthroughs with huge real-world impact, including climate tech, energy innovation, food security, and advanced materials science (nanoparticles, graphene, fireproofing materials). Life Sciences - Scalable healthcare and medtech solutions with multiple adjacencies, from medical devices to digital health platforms and surgical innovation. Identity & Security - Cybersecurity, identity protection, sensor technology, and data sovereignty solutions. Deep focus on protecting networks, infrastructure, and personal data. All three areas emphasize innovation that solves real problems and creates measurable impact. Stage Focus & Check Size Ecliptic invests exclusively across Pre-Seed, Seed, and Series A stages: Pre-Seed : $250K-$500K for early validation and prototypes Seed : $500K-$5M for companies with initial product-market signals Series A : Up to $15M for companies demonstrating product-market fit Total capital allocation ranges from $250K-$15M per investment. The firm explicitly states "100% Investment in Pre-Seed, Seed, and Series A" - they do not invest in later stages. Lead Tendency Ecliptic explicitly states they are "comfortable leading or following," indicating a balanced approach. Recent activity shows they frequently lead seed rounds (Koda Health Seed+, portfolio companies) but also co-invest and participate in rounds alongside established partners. Team & Background The firm was founded by Mike Erwin (1969-2023, founder whose legacy drives the firm's vision), along with current co-founders: Adam Lipman (Co-Founder, General Partner, CIO) - Focus on portfolio strategy and investment decisions Whurley (Co-Founder, General Partner) - Operating partner, former tech executive Varun Pandit (Partner, Portfolio and Finance) - Portfolio management and investor relations Mike Millard (Partner, Deal Flow and Strategy) - Deal sourcing and strategy James R. Puckett (Managing Partner, CFO) - Fund operations and management Greg Strake (Investor Relations) - LP relationships Collectively, the team brings 100+ years of operating experience, including successful exits, scaling operations, and deep domain expertise. Decision Process & Timeline Ecliptic uses a distinctive non-traditional process: Initial selection and mutual fit assessment Deep-dive conversations with founders Share valuable insights and strategic perspective Leverage network for introductions (customers, vendors, advisors, investors) Dispatch capital when maximum returns align with founder readiness The process is consultative and advisor-driven rather than purely financial. They emphasize "patient capital" - willingness to have extended conversations before committing funds, and hands-on support throughout the journey. Recent Activity & Portfolio Recent notable investments include: Koda Health (Life Sciences) - Seed+ round led by Ecliptic, with strategic co-investors including Memorial Hermann Health System, AARP, TMC Venture Fund Veloce Energy (Energy) - Series A closing, multiple investors Unchained Capital - Series A ($25M raised with NYDIG and Stone Ridge Holdings) Active portfolio includes 18+ companies across three focus areas: Energy & Materials : Nabaco (waste reduction), NanoTech (passive fireproofing), SurgePower (graphene materials), Veloce (EV charging) Life Sciences : Koda Health (medical planning platform), Lazarus 3D (3D printing for surgery training), Epistemix (agent-based modeling), Sempulse (biometric monitoring) Identity & Security : Authena (anti-counterfeiting), Blink Identity (access control), Persensys (drone detection), ThreatWarrior (cybersecurity) Legacy Investments : Earbuds (music), Patchr, Pluralytics (data science), Sourced Craft Cocktails, Strangeworks (quantum), Unchained (digital assets) Founder Preferences Ecliptic specifically seeks: Ex-Fortune 500 operators with entrepreneurial vision Technical founders with deep domain expertise Teams with "hands in multiple markets simultaneously" (diversified thinking) First-time founders willing to accept guidance and mentorship Founders solving real problems with measurable impact The firm celebrates that 25% of portfolio founders are women and is dedicated to increasing this number. Geographic Focus HQ is in Austin, Texas (1209 W. 5th Street). The firm shows strong commitment to supporting Texas-based founders while open to investing nationally. Portfolio companies span US locations, with particular strength in energy/climate tech hubs. Operational Support Model Ecliptic differentiates through "high engagement" - they measure 21% higher earnings through their involvement (per Forbes). They provide: Direct introductions to potential customers and strategic partners Help with organizational structure and processes Strategic guidance on critical decisions and pitfalls Network access to Fortune 500 partners and fellow founders 24/7 accessibility to portfolio companies Lead Investments & Co-Investment Network The firm explicitly states "45+ investment partners" and describes a collaborative approach. They have demonstrated co-investment partnerships with: Healthcare systems (Memorial Hermann, Texas Children's Hospital) Established funds (TMC Venture Fund) Financial institutions (NYDIG, Stone Ridge Holdings) Recent Thesis Development Ecliptic has published significant thought leadership on climate tech investing through partner David J. Neff, focusing on: Climate adaptation and building resilience Electrification and clean energy Climate-friendly materials and processes Systems-level climate solutions They also released an AI report examining impacts of AI across climate tech, cybersecurity, and healthcare - suggesting expanding interest in AI-enabled solutions across their focus areas. Fund Status The firm was founded in 2019 with Fund I of $125M. Currently deploying and actively investing (portfolio additions through 2025 including Koda Health Seed+). No public announcements of Fund II closure date, but recent investment activity and news coverage suggest active deployment from current fund. Notable Characteristics Founder-centric : Emphasis on co-founder model, not just as a bank Operational value : Former operators who have built and scaled companies Patient capital model : Willing to invest time in relationships before committing capital Impact-oriented : Focus on solving real problems, not just financial returns Transparent : Regular newsroom updates, published research, founder testimonials Accessible : 24/7 availability to portfolio and prospects Community builder : 45+ investment partners suggesting ecosystem approach